MedTrace Logo

Behavioral and Physiological Effects of THC and CBD

NCT03832816 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2019-08-05

No results posted yet for this study

Summary

This study will evaluate physiological and behavioral responses to vaporized delta9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) administered via inhalation.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Placebo

Placebo vapor (distilled water)

DRUG

Vaporized THC alone

Acute exposure to vaporized THC

DRUG

Vaporized CBD alone

Acute exposure to vaporized CBD

DRUG

Vaporized CBD with THC

Acute exposure to vaporized CBD with THC

Sponsors & Collaborators

Principal Investigators

  • Elise Weerts, PhD · Johns Hopkins University

  • Ryan Vandrey, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-31
Primary Completion
2021-12-31
Completion
2021-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03832816 on ClinicalTrials.gov